List of Contents

Glaucoma Surgery Devices Market Size, Share, and Trends 2024 to 2034

The global glaucoma surgery devices market size was USD 1.70 billion in 2023, calculated at USD 1.78 billion in 2024 and is expected to reach around USD 2.79 billion by 2034, expanding at a CAGR of 4.62% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 5028
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Glaucoma Surgery Devices Market 

5.1. COVID-19 Landscape: Glaucoma Surgery Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Glaucoma Surgery Devices Market, By Product

8.1. Glaucoma Surgery Devices Market Revenue and Volume, by Product, 2024-2034

8.1.1 Glaucoma Drainage Device

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Traditional Surgery Devic

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Diamond Knives

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Glaucoma Surgery Devices Market, By Surgery Method

9.1. Glaucoma Surgery Devices Market Revenue and Volume, by Surgery Method, 2024-2034

9.1.1. Traditional Glaucoma Surgery

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Minimal Invasive Glaucoma Surgery

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Laser Surgery

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Glaucoma Surgery Devices Market, By End-user 

10.1. Glaucoma Surgery Devices Market Revenue and Volume, by End-user, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Ophthalmic Clinics

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Glaucoma Surgery Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Surgery Method (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

Chapter 12. Company Profiles

12.1. Alcon, Inc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Glaukos Corporation

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Johnson & Johnson Vision

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. AbbVie Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. ASICO, LLC

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Carl Zeiss Meditec AG

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Katalyst Surgical

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Lumenis Lt.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Ziemer Ophthalmic Systems AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Iridex Corporation.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client